Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo

Journal of Nuclear Cardiology

Volumn 6, Issue 1, 1999, Pages 41-53

  Tsimikas, Sotirios ^a   Palinski, Wulf ^a   Halpern, Samuel E ^b   Yeung, David W ^b   Curtiss, Linda K ^c   Witztum, Joseph L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Antibodies; Arteriosclerosis; Imaging; Oxidation; Oxidized LDL; Radioisotopes

Indexed keywords

HUMAN ALBUMIN; IMMUNOGLOBULIN G1; IODINE 125; MALONALDEHYDE; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; FOAM CELL; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCINTILLATION CAMERA;

EID: 0033033340     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(99)90064-8     Document Type: Article

References (59)

1. White CW, Wright CB, Doty DB, et al. Does visual interpretation of the coronary angiogram predict physiologic significance of a coronary stenosis? N Engl J Med 1984;310:819-24.
2. Meier B, Gruentzig AR, Goebel N, Pyle R, von Gosslar W, Schlumf M. Assessment of stenoses in coronary angioplasty: inter- and intraobserver variability. Int J Cardiol 1983;3:159-69.
3. Stiehl G, Ludmilla SG, Schofer J, Donath K, Mathey DG. Impact of compensatory enlargement of atherosclerotic coronary arteries on angiographie assessment of coronary artery disease. Circulation 1989;80:1603-9.
4. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-5.
5. Furberg CD, Adams HP, Applegate WB, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 1994;90:1679-87.
6. Yock PG, Johnson EL, Linker DT. Intravascular ultrasound: development and clinical potential. Am J Card Imaging 1988;2:185-93.
7. Wong ND, Detrano RC, Abrahamson D, Tobis JM, Gardin JM. Coronary artery screening by electron beam computed tomography: facts, controversy, and future. Circulation 1995;92:632-6.
8. Yuan C, Skinner MP, Kaneko E, et al. Magnetic resonance imaging to study lesions of atherosclerosis in the hyperlipidemic rabbit aorta. Magn Reson Imaging 1996;14:93-102.
9. Constantinides P. Plaque fissures in human coronary thrombosis. J Atheroscler Res 1966;6:1-17.
10. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984;310:1137-40.
11. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-66.
12. Hackett D, Davies MJ, Maseri A. Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. Eur Heart J 1988;9:1317-23.
13. Lendon CL, Davies MJ, Born GVR, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 1991;87:87-90.
14. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
15. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
16. Shah PK, Falk E, Badimon JJ, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Circulation 1995;92:1565-9.
17. Lees RS, Lees AM, Strauss HW. External imaging of human atherosclerosis. J Nucl Med 1983;24:154-6.
18. Lees AM, Lees RS, Schoen FJ, et al. Imaging human atherosclerosis with Tc-99m-labeled LDL. Arterioscler Thromb 1988;8:461-70.
19. Rosen JM, Butler SP, Meineken GE, et al. Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistribution. J Nucl Med 1990;31:343-50.
20. 123I-labeled synthetic peptide fragment. J Clin Pharmacol 1993;33:1039-47.
21. Davis HH II, Siegel BA, Sherman LA, et al. Scintigraphic detection of carotid atherosclerosis with indium-111-labeled autologous platelets. Circulation 1980;61:982-8.
22. Minar E, Ehringer H, Dudczak R, et al. Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. Stroke 1989;20:27-33.
23. Moriwaki H, Matsumoto M, Handa N, et al. Functional and anatomic evaluation of carotid atherothrombosis: a combined study of indium 111 platelet scintigraphy and B-mode ultrasonography. Arterioscler Thromb Vasc Biol 1995;15:2234-40.
24. Miller DD, Boulet AJ, Tio FO, et al. In vivo technetium-99m S12 antibody imaging of platelet alpha-granules in rabbit endothelial neointimal proliferation after angioplasty. Circulation 1991;83:224-36.
25. Fischman AJ, Rubin RH, Khaw BA, et al. Radionuclide imaging of experimental atherosclerosis with nonspecific polyclonal immunoglobulin G. J Nucl Med 1989;30:1095-100.
26. Demacker PNM, Dormans TPJ, Koenders EB, Corstens FHM. Evaluation of indium-111-polyclonal immunoglobulin G to quantitate atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy. effect of age and treatment with antioxidants or ethinylestradiol. J Nucl Med 1993;34:1316-21.
27. Palac RT, Gray LL, Turner FE, Brown PH, Malinow MR, Demots H. Detection of experimental atherosclerosis with indium-111 radiolabeled hematoporphyrin derivative. Nucl Med Comm 1989;10:841-50.
28. 131I-Ama MoAb in atherosclerotic rabbits. Nucl Med Biol 1995;22:693-7.
29. Narula J, Petrov A, Bianchi C, et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab′)2 specific for the proliferating smooth muscle cells of human atheroma: imaging with conventional and negative charge-modified antibody fragments. Circulation 1995;92:474-84.
30. Palinski W, Ylä-Herttuala S, Rosenfeld ME, et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arterioscler Thromb 1990;10:325-35.
31. Palinski W, Rosenfeld ME, Ylä-Herttuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci 1989;86:1372-6.
32. Palinski W, Hörkkö S, Miller E, et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice: demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 1996;98:800-14.
33. Steinbrecher UP. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem 1987;262:3603-8.
34. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
35. Rosenfeld ME, Palinski W, Ylä-Herttuala S, Butler SW, Witztum JL. Distribution of oxidation-specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arterioscler Thromb 1990;10:336-49.
36. Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci 1995;92:821-5.
37. Boyd HC, Gown AM, Wolfbauer G, Chait A. Direct evidence for a protein recognized by a MoAb against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol 1989;135:815-25.
38. Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 1988;241:215-8.
39. Palinski W, Tangirala RK, Miller E, Young SG, Witztum JL. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:1569-76.
40. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 1994;14:605-16.
41. Ylä-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-95.
42. Jürgens G, Chen Q, Esterbauer H, Mair S, Ledinski G, Dinges HP. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). Arterioscler Thromb 1993;13:1689-99.
43. Hammer A, Kager G, Dohr G, Rabl H, Ghassempur I, Jürgens G. Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins. Arterioscler Thromb Vasc Biol 1995;15:704-13.
44. Jue R, Lambert JM, Pierce LR, Traut RR. Addition of sulfhydryl groups to Escherichia coli ribosomes by protein modification with 2-iminothialane (methyl 4-mercaptobutyrimidate). Biochemistry 1978;17:5399-416.
45. Hörkkö S, Miller E, Dudl E, et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996;98:815-25.
46. Habeeb ASSA. Chemical evaluation of conformational differences in native and chemically modified proteins by trinitrobenzenesulfonic acid. Biochim Biophys Acta 1966;115:440-54.
47. Fruebis J, Carew TE, Palinski W. Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits. Arterioscler Thromb Vasc Biol 1995;117:217-24.
48. Tangirala RK, Rubin EM, Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apoprotein E-deficient mice. J Lipid Res 1995;36:2320-8.
49. Palinski W, Koschinsky T, Butler SW, et al. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler Thromb Vasc Biol 1995;15:571-82.
50. 125I-labeled plasma protein influx in normal and atheromatous rabbit aorta. J Atheroscler Res 1968;8:679-96.
51. Christensen S, Nielsen H. Permeability of arterial endothelium to plasma macromolecules. Atherosclerosis 1977;27:447-63.
52. Smith EB, Staples EM. Distribution of plasma proteins across the human aortic wall. Atherosclerosis 1980;37:579-90.
53. Jensen JS. Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:1324-9.
54. Wu CC, Chang SW, Chen MS, Lee YT. Early change of vascular permeability in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 1995;15:529-33.
55. Witztum JL. Role of oxidised low density lipoprotein in atherogenesis. Br Heart J 1993;69:S12-S18.
56. Scanlon CEO, Berger B, Malcom G, Wissler RW. Evidence for more extensive deposits of epitopes of oxidized low density lipoprotein in aortas of young people with elevated serum thiocyanate levels. Atherosclerosis 1996;121:23-33.
57. Rosenfeld ME, Tsukada T, Chait A, Bierman EL, Gown AM, Ross R. Fatty streak expansion and maturation in Watanabe heritable hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1987;7:24-34.
58. Sinitsyn W, Mamontova AG, Checkneva W, Shnyra AA, Domogatsky SP. Rapid blood clearance of biotinylated IgG after infusion of avidin. J Nucl Med 1989;30:66-9.
59. Paganelli G, Malcovati M, Fazio F. Monoclonal antibody pretargetting techniques for tumour localization: the avidin-biotin system. Nucl Med Comm 1991;12:211-34.